| Print
Ironwood Pharmaceuticals (IRWD)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses,commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Address
100 Summer Street
Suite 2300
Boston
MA
USA
02110
Telephone
+1 617 621-7722
Forecast key dates
| Name | Key Date |
|---|---|
| Ironwood Pharmaceuticals Inc Third Quarter Earnings Results for 2026 | 2026-11-10T00:00:00 |
| Ironwood Pharmaceuticals Inc Second Quarter Earnings Results for 2026 | 2026-08-07T00:00:00 |
| Ironwood Pharmaceuticals Inc Annual General Meeting for 2026 | 2026-06-10T09:00:00 |
| Ironwood Pharmaceuticals Inc First Quarter Earnings Result for 2026 | 2026-05-07T00:00:00 |
| Ironwood Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026 | 2026-05-07T00:00:00 |
| Ironwood Pharmaceuticals Inc Annual Report for 2025 | 2026-03-31T00:00:00 |
| Ironwood Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-27T08:30:00 |
| Ironwood Pharmaceuticals Inc Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Ironwood Pharmaceuticals Inc Third Quarter Earnings Results for 2025 | 2025-11-10T00:00:00 |
| Ironwood Pharmaceuticals Inc Second Quarter Earnings Results for 2025 | 2025-08-07T00:00:00 |
| Ironwood Pharmaceuticals Inc Annual General Meeting for 2025 | 2025-06-10T09:00:00 |
| The Citizens Life Sciences Conference | 2025-05-07T12:00:00 |
| Ironwood Pharmaceuticals Inc First Quarter Earnings Result for 2025 | 2025-05-07T00:00:00 |
| Ironwood Pharmaceuticals Inc Annual Report for 2024 | 2025-03-31T00:00:00 |
| Ironwood Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-02-27T08:30:00 |
| Ironwood Pharmaceuticals Inc Fourth Quarter Earnings Result for 2024 | 2025-02-27T00:00:00 |
| Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference | 2024-12-04T12:30:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.